华神科技：关于公开挂牌转让控股子公司51%股权的进展公告

Core Points - Huasheng Technology announced the intention to publicly transfer 51% equity of its subsidiary, Tibet Kangyu Pharmaceutical Co., Ltd. [1] - The second round of the transfer announcement period ended without attracting qualified interested buyers, prompting the company to re-list the equity for sale [1] - The expected public listing period for this transfer is from September 5, 2025, for five working days, with a listing price set at 42.5 million yuan [1]